Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Caribou Biosciences Says CRISPR CAR-T Is Pivotal-Ready, CB-011 Data Nears

Caribou Biosciences (NASDAQ:CRBU) Chief Executive Officer Rachel Haurwitz said the company is advancing two CRISPR-enabled, off-the-shelf CAR T cell therapy programs, with its lymphoma candidate vispa-cel now “pivotal-ready” and its multiple myeloma program CB-011 continuing in Phase 1 development.

MarketBeat

Unsanitary meat factory shut down, products sold nationwide

PATHUM THANI – A meat processing factory that sells about 30 tonnes of branded products nationwide each month was shut down after failing to meet sanitary standards on Tuesday.

Bangkok Post

Corbus Pharmaceuticals Teases Cancer, Obesity Data as Key Clinical Readouts Near

Corbus Pharmaceuticals (NASDAQ:CRBP) Chief Executive Yuval Cohen outlined the company’s near-term clinical readout schedule and development plans for its two lead drug candidates during a Jefferies fireside chat hosted by biotech analyst Amin Makarem. Cohen said the Norwood, Massachusetts-based dru

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

GSK makes biggest ever acquisition with $10.6bn for US cancer drug firm

Nuvalent’s late-stage lung cancer treatments zidesamtinib and neladalkib are expected to launch later this year

The Guardian - UK

Compass Therapeutics Eyes FDA Path After Tovecimig Trial Win

Compass Therapeutics (NASDAQ:CMPX) Chief Executive Officer Tom Schuetz said the company is preparing for a key U.S. Food and Drug Administration meeting on tovecimig, its DLL4/VEGF bispecific antibody, after a randomized study in advanced biliary tract cancer met its primary endpoint and a key secon

MarketBeat

Click with caution

According to the Technology Crime Suppression Division, the Central Investigation Bureau (CIB), there were over 50,000 cases of online shopping fraud from January to March, including delivery of products that did not match their advertisement and non-delivery even though payment had been made. The total damage exceeded 600 million baht.

Bangkok Post

CG Oncology Touts Cretostimogene Data, BLA Progress in Bladder Cancer Push

CG Oncology (NASDAQ:CGON) is focused on advancing cretostimogene, an oncolytic immunotherapy for non-muscle invasive bladder cancer, Chief Executive Officer Arthur Kuan said during a discussion at the Jefferies Global Healthcare Conference in New York. Kuan said the company believes the therapy cou

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

'They Abandoned Women': Trump Administration Under Fire for Leaving 'Deadly' Abortion Pills Unregulated

Campaigners are accusing Donald Trump's administration of leaving abortion pills dangerously under-regulated, pointing to a string of US criminal cases where women say they were secretly drugged.

International Business Times UK

CDC Expands Salmonella Warning as Outbreak Spreads to 119 Cases Across 36 States

CDC expands a Salmonella outbreak linked to moringa supplements, now reaching 119 cases in 36 states. CDC warns of ongoing risk, recalls issued nationwide, and urges consumers to check homes for contaminated products.

Medical Daily

Popular over-the-counter gas medication sold in US recalled for possible contamination

The medication was sold at retailers nationwide

The Independent UK

Trump tariffs changed taste of foods in U.S? Label checking reveals shocking details

Trump Tariffs have grabbed headlines and become the topic of discussion around the world. Now there is a reality-check on the food ingredients.

The Economic Times

Ozempic Is Now Fighting America's Addiction Crisis — A Massive VA Study Covering 600,000 Veterans Is Rewriting What We Know About Substance Abuse

Drugs like Ozempic and Wegovy — already reshaping obesity treatment — may also slash overdose deaths, ER visits, and alcohol dependence, according to the largest study ever conducted on GLP-1s and addiction.

Medical Daily

Black Diamond Therapeutics Touts Silevertinib Lung Cancer Data, Eyes FDA Path

Black Diamond Therapeutics (NASDAQ:BDTX) is positioning its lead oncology drug candidate, silevertinib, as a potential treatment for non-small cell lung cancer patients with non-classical EGFR mutations, Chief Executive Officer Mark Velleca said during a Jefferies fireside chat following the company

MarketBeat

Axsome Therapeutics Readies Auvelity Alzheimer’s Agitation Launch, Expands CNS Pipeline

Axsome Therapeutics (NASDAQ:AXSM) executives said the company is preparing to launch Auvelity in Alzheimer’s disease agitation this month while continuing to expand the drug’s use in major depressive disorder and advance a broad central nervous system pipeline. Speaking at a Jefferies fireside chat

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead

Avalyn Pharma (NASDAQ:AVLN) executives outlined the company’s inhaled pulmonary fibrosis strategy at the Jefferies Global Healthcare Conference, emphasizing its recent IPO, ongoing mid-stage studies and plans to position its candidates as potential backbone therapies for idiopathic pulmonary fibrosi

The Independent UK

Target issues urgent recall of baby wipes sold across the US

Two types of baby wipes have been affected by the recall

The Independent UK

RFK Jr’s FDA to study if abortion pill mifepristone is safe despite it being on market for over 25 years: report

Roughly 7.5 million women have taken the pill over the past 25 years

Medical Daily

With Nation's Highest Diabetes Rate, San Antonio Faces Major Shift as Medicare Prepares $50 Wegovy Coverage

With diabetes rates among the highest in the U.S., San Antonio could see major change as Medicare's new $50 Wegovy coverage begins July 1, expanding access for eligible residents.

Get all your
news in one place.

100's of premium titles.
One news app.

Bangkok Post

Almost 15,000 illegal health products seized in Bangkok warehouse raid

A warehouse raid in Bangkok’s Lat Krabang district seeking illegal dietary supplements, cosmetics and herbal products seized nearly 15,000 items worth more than 2 million baht on Friday.

MarketBeat

Alvotech Nears Inflection Point With 5 U.S. Biosimilars Targeted by Year-End

Alvotech (NASDAQ:ALVO) is at an “inflection point” after more than a decade of investment in its biosimilar platform, Founder and Executive Chairman Róbert Wessman said at the Jefferies Global Healthcare Conference in New York. Speaking with Jefferies analyst Marco Baruzzi, Wessman said Alvotech ha

MarketBeat

Aldeyra Therapeutics Eyes FDA Feedback as Dry Eye Drug Faces Make-or-Break Moment

Aldeyra Therapeutics (NASDAQ:ALDX) Chief Executive Todd Brady said the company expects near-term feedback from the U.S. Food and Drug Administration on its dry eye disease candidate reproxalap, following a third complete response letter tied to efficacy questions. Speaking at a Jefferies fireside c

AAP

Optellum Celebrates Accelerating Impact in Lung Cancer Care; Now at Over 250 Sites and Growing

OXFORD, United Kingdom and HOUSTON, June 5, 2026 /PRNewswire/ -- Optellum, a leader in AI-enabled lung cancer diagnostics, today announced that it has surpassed 250 clinical sites and analyzed more than 3 million cases to date. This milestone underscores Optellum's commitment to empowering health systems and clinical care teams with…

Medical Daily

"Transformative Advance" in Cancer Treatment Emerges in Dallas — New Pill Shows Rare Survival Jump in Pancreatic Cancer Patients

Pancreatic Cancer treatment may be entering a new era as a breakthrough pill nearly doubles survival in metastatic patients, offering new hope for one of the deadliest forms of cancer.

Fortune

I bought peptides with crypto. How my purchase helped fuel a $100 million gray-market, ‘looksmaxxing’ economy

Some of the China-based sellers have pivoted from fentanyl to peptides.

The Economic Times

20,000 kg sugar-mixed jaggery, coloured peas seized in Pune food safety department raids

The FDA in Pune seized 16 tonnes of jaggery and 20 tonnes of sugar intended for adulteration, alongside 68 kg of artificially coloured fried green peas. Raids also uncovered adulterated flour, hoarded areca nuts, and banned gutka products, with three establishments issued stop-work notices for unhygienic conditions and operating without…

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.